Prevention of cerebral palsy, autism spectrum disorder, and attention deficit-hyperactivity disorder - PubMed (original) (raw)
Prevention of cerebral palsy, autism spectrum disorder, and attention deficit-hyperactivity disorder
Alan D Strickland. Med Hypotheses. 2014 May.
Abstract
This hypothesis states that cerebral palsy (CP), autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD) are all caused by an exaggerated central nervous system inflammatory response to a prenatal insult. This prenatal insult may be one or more episodes of ischemia-reperfusion, an infectious disease of the mother or the fetus, or other causes of maternal inflammation such as allergy or autoimmune disease. The resultant fetal inflammatory hyper-response injures susceptible neurons in the developing white matter of the brain in specific areas at specific gestational ages. The exaggerated neuroinflammatory response is theorized to occur between about 19 and 34 post-conception weeks for CP, about 32 and 40 weeks for ADHD, and about 36 and 48 weeks (i.e. 2 months after delivery) for ASD. The exaggerated inflammatory response is hypothesized to occur because present diets limit intake of effective antioxidants and omega-3 polyunsaturated fatty acids while increasing intake of omega-6 polyunsaturated fatty acids. Oxidation products of the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) limit neuroinflammation while oxidation products of the omega-6 fatty acid arachidonic acid exacerbate inflammation. Preventative treatment should begin in all pregnant women during the first trimester and should include both DHA and an effective antioxidant for prevention of neuroinflammation. The suggested antioxidant would be N-acetylcysteine, though melatonin could be chosen instead. Combined DHA and NAC therapy is theorized to decrease the incidence of the three disorders by more than 75%.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
- Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS, Conquer JA, Thomas R. Young GS, et al. Reprod Nutr Dev. 2005 Sep-Oct;45(5):549-58. doi: 10.1051/rnd:2005045. Reprod Nutr Dev. 2005. PMID: 16188207 Clinical Trial. - The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder - a review.
Martins BP, Bandarra NM, Figueiredo-Braga M. Martins BP, et al. Crit Rev Food Sci Nutr. 2020;60(9):1431-1446. doi: 10.1080/10408398.2019.1573800. Epub 2019 Mar 18. Crit Rev Food Sci Nutr. 2020. PMID: 30880398 Review. - Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
Gow RV, Matsudaira T, Taylor E, Rubia K, Crawford M, Ghebremeskel K, Ibrahimovic A, Vallée-Tourangeau F, Williams LM, Sumich A. Gow RV, et al. Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):151-6. doi: 10.1016/j.plefa.2008.12.007. Epub 2009 Feb 20. Prostaglandins Leukot Essent Fatty Acids. 2009. PMID: 19230637 - Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.
Janssen CI, Kiliaan AJ. Janssen CI, et al. Prog Lipid Res. 2014 Jan;53:1-17. doi: 10.1016/j.plipres.2013.10.002. Epub 2013 Oct 24. Prog Lipid Res. 2014. PMID: 24334113 Review. - Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR. Milte CM, et al. Nutrition. 2012 Jun;28(6):670-7. doi: 10.1016/j.nut.2011.12.009. Epub 2012 Apr 25. Nutrition. 2012. PMID: 22541055 Clinical Trial.
Cited by
- Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.
Cubero-Millán I, Molina-Carballo A, Machado-Casas I, Fernández-López L, Martínez-Serrano S, Tortosa-Pinto P, Ruiz-López A, Luna-del-Castillo JD, Uberos J, Muñoz-Hoyos A. Cubero-Millán I, et al. Int J Mol Sci. 2014 Sep 25;15(9):17115-29. doi: 10.3390/ijms150917115. Int J Mol Sci. 2014. PMID: 25257531 Free PMC article. Clinical Trial. - Potential Benefits of Ameliorating Metabolic and Nutritional Abnormalities in People With Profound Developmental Disabilities.
Glick NR, Fischer MH. Glick NR, et al. Nutr Metab Insights. 2017 Jun 28;10:1178638817716457. doi: 10.1177/1178638817716457. eCollection 2017. Nutr Metab Insights. 2017. PMID: 35185339 Free PMC article. - Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD).
Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salomäki S, Sucksdorff M, Surcel HM, Upadhyaya S, Sourander A. Chudal R, et al. Eur Child Adolesc Psychiatry. 2020 Feb;29(2):239-247. doi: 10.1007/s00787-019-01372-y. Epub 2019 Jul 16. Eur Child Adolesc Psychiatry. 2020. PMID: 31312974 Free PMC article. - Nutritional and Metabolic Biomarkers in Autism Spectrum Disorders: An Exploratory Study.
Esparham AE, Smith T, Belmont JM, Haden M, Wagner LE, Evans RG, Drisko JA. Esparham AE, et al. Integr Med (Encinitas). 2015 Apr;14(2):40-53. Integr Med (Encinitas). 2015. PMID: 26770138 Free PMC article. - Intake of Caffeinated Soft Drinks before and during Pregnancy, but Not Total Caffeine Intake, Is Associated with Increased Cerebral Palsy Risk in the Norwegian Mother and Child Cohort Study.
Tollånes MC, Strandberg-Larsen K, Eichelberger KY, Moster D, Lie RT, Brantsæter AL, Meltzer HM, Stoltenberg C, Wilcox AJ. Tollånes MC, et al. J Nutr. 2016 Sep;146(9):1701-6. doi: 10.3945/jn.116.232272. Epub 2016 Aug 3. J Nutr. 2016. PMID: 27489007 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous